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The murine epidermis contains two types of dendritic
cells (DC), Thy-11 dendritic epidermal T cells (DETC)
and Langerhans cells. In this review, we introduce our
data obtained using a skin organ culture system to
examine the migratory capacity of DETC and Langerhans
cells into the epidermis. DETC or Langerhans cells were
depleted by topical application of clobetazole propionate
(CP) solution onto the murine ears. CP-treated or
untreated ear skin was co-cultured with syngeneic (semi-
syngeneic, or allogenic, in experiments with Langerhans
cells) epidermal cell suspension. We found (i) that donor
DETC or Langerhans cells migrated into the CP-treated
The epidermal milieu of murine skin contains two types ofdendritic cells (DC) that participate in the immunologicreactions of the skin as immunocompetent cells: dendriticepidermal T cells (DETC) and epidermal Langerhanscells. DETC are unique T cells that mainly consist of
cells expressing γδ T cell receptor (TCR); however, αβ TCR-
expressing T cells also exist in the epidermis in particular situations
such as in chimeric mice (Shiohara et al, 1993). Among
γδTCR1DETC, Vγ3/Vδ1 expressing DETC are predominant; how-
ever, other γδ T cells expressing Vγ12, Vγ4, and Vδ4 also exist,
although these cells represent minor populations (Payer et al, 1995).
The majority of γδTCR expressing DETC, which express Vγ3/Vδ1,
are believed to originate from day 16 murine fetal thymocytes and to
migrate into the epidermis during ontogeny.
Few studies have focused on migration of DETC from the
epidermis. Kaminski et al showed that application of irritant and contact
allergens induced activation and emigration of DETC by a mechanism
that is not well understood (Kaminski et al, 1993). Larson et al found
that DC emigrated into culture medium in large numbers when pieces
of murine ear skin were cultured dermal-side-down for 1 d (Larson
et al, 1990). The cells had the same features as mature DC and DETC.
The mechanism of emigration of DETC in this organ culture system
needs to be clarified.
Epidermal Langerhans cells, another type of immunocompetent DC
in the epidermal milieu, originate from bone marrow and migrate into
the epidermis. Epidermal Langerhans cells have the capacity to acquire
and process antigens (Ag) and transport them to regional lymph nodes.
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epidermis as well as into untreated epidermis, (ii) that
leukosialin Ly48 recognized by monoclonal antibody S11
and TNF-a strongly inhibited donor Langerhans cell
migration into the epidermis. We mention other mole-
cules that may participate in the migration of Langerhans
cells such as chemotactic cytokines, monocyte chemo-
attractant protein (MCP)-1, TGF-b and skin-homing
molecule, cutaneous lymphocyte-associated antigen
(CLA) on Langerhans cells. Keywords: Langerhans cells/
DETC/CLA/chemokine/TGF-b. Journal of Investigative
Dermatology Symposium Proceedings, 4:169–172, 1999
Marked changes of surface phenotype and functional activity of
Langerhans cells occur concomitantly with Ag acquisition and migra-
tion. The abilities of Langerhans cells to localize in the epidermis of
the skin from bone marrow and to migrate from the epidermis to
regional lymph nodes after Ag exposure represent essential features of
Langerhans cells, and it is likely that these processes are regulated
(Banchereau and Steinman, 1998).
Much of what is known about DC migration in the epidermis
comes from studies on Langerhans cells, especially on the emigration
of Langerhans cells from the epidermis to the regional lymph nodes.
IL-1 and TNF-α are involved in the migration of Langerhans cells
from the epidermis to the regional lymph nodes (Kimber et al, 1993).
Application of contact allergens induced emigration of Langerhans cells
and enhanced detection of mRNA of cytokines such as IL-1 and
TNF-α (Enk and Katz, 1992). Administration of anti-IL-1β and anti-
TNF-α antibodies inhibited contact allergen-induced sensitization and
Langerhans cell redistribution. Also, dermal injection of IL-1 or TNF-α
induced a decrease of Langerhans cells in the epidermis, and an increase
of DC in draining lymph nodes (Enk et al, 1993). A very recent study
revealed that IL-1 and TNF-α act directly on Langerhans cells,
reduce the E-cadherin mRNA level, downregulate E-cadherin surface
expression, and induce a loss of E-cadherin-mediated adhesion, such
as the interaction among Langerhans cells and keratinocytes (KC)
(Jakob and Udey, 1998). In addition, α6 integrins on Langerhans cells
may be necessary for Langerhans cell emigration (Price et al, 1997),
and matrix metalloproteinase 9 (MMP-9) may also play a role in the
migration of Langerhans cells by degrading basement membrane
proteins (Kobayashi, 1997). Few studies, however, have been conducted
to elucidate the mechanism of the migration of Langerhans cells into
the epidermis. It was only reported that Langerhans cells are derived
from bone marrow in experiments using a chimeric bone marrow
transplant model (Katz et al, 1979).
To analyze the migration of DETC and Langerhans cells into the
epidermis (Tamaki et al, 1994; Saitoh et al, 1998), we developed an
in vitro model and studied the migration of DETC and Langerhans
cells. In this review, we summarize the in vitro culture system and
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describe the molecules responsible for the migration of DETC and
Langerhans cells into the epidermis in this skin organ culture system.
MATERIALS AND METHODS
Animals Female BALB/c, C3H/He, and (C3H/He3BALB/c) mice were
obtained from the Shizuoka Agricultural Cooperative Association for Laboratory
Animals, Hamamatsu, Japan.
Reagents Monoclonal antibodies (MoAb) against mouse Thy-1.2 (rat IgG2b),
Iad (mouse IgG2a), Iak (mouse IgG2b), and FITC-conjugated anti-mouse Thy-
1.2 were obtained from Becton Dickinson (Sunnyvale, CA). FITC-conjugated
anti-rat IgG antibody and FITC-conjugated goat anti-mouse IgG (Cappel,
Durham, NL) were used for the second staining. MoAb against mouse ICAM-
1 (hamster IgG), LFA-1 (rat IgG2b), CD44 (rat IgG2b), and GM-CSF (rat
IgG1) were obtained from PharMingen (San Diego, CA). Polyclonal Ab against
TNF-α (rabbit IgG, IgM) and IL-1α (rabbit IgG, IgM) were obtained from
Genzyme (Cambridge, MA). MoAb against IL-2 (rat IgG2a) was obtained from
Endogen (Woburn, MA). Rabbit Ab against mouse fibronectin (i852) (rabbit
serum) was obtained from Bioproducts (Vallensbaek Strand, Denmark). MoAb
against murine laminin (rat IgG1) was obtained from Chemicon International
(Temecula, CA). Ly48 (3E8 rat IgG2a, S7 rat IgG2a, S11 rat IgG2b, and S15
rat IgM) were kindly provided by Dr J.G. Frelinger (University of Rochester).
For isotype-matched controls for Thy-1.2, Iad, and Iak staining, rat IgG2b,
mouse IgG2a, and mouse IgG2b were used, respectively, and negative results
were always obtained. For isotype-matched controls for the migration assay, rat
IgG1, rat IgG2a, rat IgG2b, hamster IgG (PharMingen), mouse IgG2a, mouse
IgG2b (Becton Dickinson), and rabbit serum (ILB, Gunma, Japan) were used,
and they had no effect on migration of DETC and Langerhans cells.
Preparation of epidermal cell suspension Skin from murine trunks was
incubated in 1.0% trypsin solution for 1 h to separate the epidermis from the
underlying dermis. The epidermal sheets were further treated with 0.05%
DNase for 20 min, and a single cell suspension was obtained as previously
described (Tamaki et al, 1979). The viability of epidermal cells was always
greater than 90%.
Epidermal cell cultures Epidermal cell suspensions were seeded into
RPMI1640 medium supplemented with 10% fetal calf serum, penicillin G,
streptomycin, and amphotericin B, in 10 mm tissue culture dishes at 37°C at a
density of 13107 cells per dish. After 3 d of culture, the non-adherent fraction
was collected and the cells therein were enumerated.
Topical application of clobetazole propionate (CP) solution One
hundred microliters of 0.05% clobetazole propionate solution (CP, Glaxo
Holdings, London, U.K.) was topically applied onto the ear skin of BALB/C
mice or C3H/He mice twice a day for 7 d.
Co-culture of epidermal cells with CP-treated skin Normal or CP-
treated murine ear skin (about 10 mm 310 mm) was cultured in the presence
or absence of syngeneic epidermal cell suspension (13107 per ml) dermal-side-
up for 3 d using a donut-shaped plastic cylinder. In the experiments using
Langerhans cells, semisyngeneic or allogeneic epidermal cells, besides syngeneic
epidermal cells, were co-cultured with ear skin. After 3 d of culture, the skin
was removed and the recipient epidermis was separated and stained as described
below. Co-culture of cultured epidermal cell suspension (13107 per ml) and
CP-treated ear skin was performed in the same manner.
Separation and immunostaining of epidermal sheet The epidermis was
separated from the dermis after incubation with 0.5 M NH4SCN (Sigma,
St Louis, MO). After fixation with acetone at –20°C for 20 min, the epidermal
sheet was incubated with FITC-conjugated anti-Thy-1.2 MoAb, or anti-Ia
MoAb followed by FITC-conjugated goat anti-mouse IgG as previously
described (Shibagaki et al, 1991).
Blocking of DETC or Langerhans cell migration by various
antibodies To assess the effects of various antibodies on the migration of
DETC and Langerhans cells, CP-treated skin was co-cultured with syngeneic,
freshly prepared epidermal cells in the presence of the various blocking Ab
described above.
Quantitative analysis of epidermal DETC and Langerhans
cells Immunolabeled cells in the epidermal sheet were enumerated by using
a rectangular occular grid with a 403 objective as previously described
(Shibagaki et al, 1991). Briefly, three to ten areas per mm2 were randomly
chosen from each epidermal sheet, and the number of stained cells per mm2
was determined. Experimental groups comprised three to six sheets of ear skin
for each treatment. Experiments were performed at least three times and
representative results are presented. The density of DETC or Langerhans cells
is expressed as the number of Thy-1.21 cells or Ia1 cells (mean) per mm2,
respectively.
Statistical analysis Student’s t-test was performed to test for the significance,
and values of p,0.05 were considered significant.
RESULTS
DETC migrate into the normal and CP-treated epidermis The
topical application of CP onto the C3H ear skin for 5 d strongly
reduced the number of DETC in the epidermis (normal epidermis,
1285 per mm2; CP-treated epidermis, 184 per mm2). The non-treated
or CP-treated C3H ear skin (DETC-depleted skin) was co-cultured
dermal-side-up with or without the syngeneic epidermal cells for 3 d.
The cultures without added epidermal cells decreased numbers of
DETC in non-treated skin (from 1312 per mm2 to 498 per mm2).
When syngeneic C3H epidermal cells were co-cultured with non-
treated ear skin for 3 d, there was a 2- to 3-fold increase of the number
of DETC. When C3H epidermal cells were co-cultured with CP-
treated ear skin for 3 d, there was a 5- to 7-fold increase in the number
of DETC in the epidermis (from 181 per mm2 to 860 per mm2). The
total number of DETC migrating into the epidermis, however, was
similar to both DETC-depleted skin and normal skin.
Langerhans cells migrate into the normal and CP-treated
epidermis The topical application of CP onto the BALB/C ear skin
for 7 d drastically reduced the number of Ia1 Langerhans cells in the
epidermis (normal epidermis, 1533.9 per mm2; CP-treated epidermis,
46.0 per mm2). The no-treated or Cp-treated BALB/C ear skin
(LC-depleted skin) was co-cultured dermal-side-up with or without
the syngeneic (BALB/c), semisyngeneic ([BALB/C3C3H]F1), or
allogeneic (C3H/He) epidermal cells for 3 d. The cultures without
added epidermal cells decreased numbers of Langerhans cells in non–
treated skin (from 1538.7 per mm2 to 886.0 per mm2). In contrast,
in vitro culturing itself did not induce an additional decrease of
Langerhans cells in LC-depleted skin (from 80.3 per mm2 to 107.9
per mm2). When the freshly prepared, syngeneic BALB/C epidermal
cells were co-cultured with non-treated skin, a significant, but not
marked, increase of Langerhans cells was observed. In contrast, the
density of Ia1 Langerhans cells was enormously increased in LC-
depleted skin after incubation with either freshly prepared (from 80.3
per mm2 to 602.2 per mm2) or cultured syngeneic BALB/C epidermal
cells (from 80.3 per mm2 to 571.1 per mm2). The increase of the
number of semisyngeneic and allogeneic donor Langerhans cells
was very small, if any, compared with that of syngeneic donor
Langerhans cells.
Leukosialin Ly48 and TNF-a modulate DETC migration into
the epidermis in skin organ culture Because DETC migrated
into the epidermis of organ-cultured skin, we studied the mechanism
of this phenomenon. Because DETC migration in this system is
presumably through the dermis, we hypothesized that there must be
various migration pathways. For this reason, we used various Ab as
described above. These MoAb were added with epidermal cell suspen-
sions at the beginning of culture.
A MoAb against a leukosialin epitope, recognized by S11, and
polyclonal Ab against TNF-α significantly inhibited the migration of
DETC into the epidermis [66.0% (p,0.01) and 56.9% (p,0.01),
respectively]. Although S11 significantly inhibited the migration of
DETC into the epidermis, other MoAb for Ly48 such as S15, 3E8, or
S7 did not inhibit their migration into the epidermis. MoAb S11
and Ab against TNF-α again significantly inhibited their migration;
however, these were not synergistic in their inhibition (Fig 1). The
other Ab did not modulate the migration of DETC into the epidermis.
IL-6 and TNF-a partially modulate LC migration into the
epidermis in skin organ culture To characterize the migratory
capacity of Langerhans cells, we examined the effects of various
antibodies on the number of donor Langerhans cells in the recipient
epidermis. Anti-IL-6 and anti-TNF-α Ab significantly decreased the
number of Langerhans cells, by 58.2% (p,0.01) and 46.4% (p,0.01)
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Figure 1. MoAb against TNF-a or CD43 (leukosialin, S11) inhibits the
migration of DETC into the epidermis. C3H mouse ear skin was co-
cultured with syngeneic epidermal cell suspension for 3 d. Different antibodies
(MoAb against TNF-α or S11) were added to each culture. The number of
donor DETC was estimated after staining with FITC-Thy-1.2 MoAb and
presented as the mean (6 SD). *P,0.01 compared with control.
respectively. No additive inhibitory effect on the number of donor
Langerhans cells was observed in the presence of anti-IL-6 plus anti-
TNF-α Ab (% inhibition 5 54.1%). The other Ab, such as anti-
CD44, anti-GM-CSF, anti-fibronectin, anti-laminin, and anti-IL-1α,
did not alter the number of Langerhans cells in the epidermis.
DISCUSSION
DETC was originally found as Thy-11 dendritic epidermal cells
(Thy-11DETC) (Tschachler et al, 1983). These cells were believed to
be of bone marrow origin. The experiments of Havran et al, however,
convincingly revealed, by fetal thymic engraftment into nu/nu mice,
that DETC were of fetal thymic origin, although the mechanisms of
DETC migration into the epidermis are not fully understood (Havran
and Allison, 1990). Chung et al addressed the question of whether KC
could attract DETC, using the Boyden chamber method. They
found (i) that the supernatant of cultured KC (PAM212) but not of
fibroblasts caused chemotaxis for DETC, (ii) that this molecule was
over 12 kDa and trypsin sensitive, and (iii) that IL-Iα, IL-2, IL-4,
IL-7, IL-8, TNF-α, and GM-CSF did not cause such chemotactic
activity (Chung et al, 1993).
Herein, we introduced our data obtained using a skin organ culture
system in vitro (Tamaki et al, 1994). In this study, DETC was depleted
in vivo by daily application of CP solution topically onto the ears of
mice. Seven days later, ear skin was harvested, dispersed, and cultured
with syngeneic epidermal cells suspensions with a migration chamber
for 3 d. It was found that DETC migrated into the epidermis devoid
of DETC, as well as into the untreated epidermis, and blocking studies
with various antibodies revealed that leukosialin Ly48 (S11) and TNF-α
were important for DETC migration into the epidermis (Fig 1).
Langerhans cells are another type of DC residing in the murine
epidermis. Although Langerhans cells can carry Ag via draining
lymphatic to regional lymph nodes to maximize the efficiency of Ag
presentation to T cells as described above, the mechanism by which
Langerhans cells circulate to migrate to the skin has not been well
explored. When GM-CSF was injected subcutaneously, Langerhans
cells migrated into the local dermis through the peripheral blood
(Kaplan et al, 1992).
To clarify the mechanism of Langerhans cell migration into the skin,
we examined the capability of Langerhans cell migration using an
in vitro skin organ culture system, and examined the ability of Langerhans
cells to migrate into the epidermis. Ear skin treated with CP solution
was co-cultured with syngeneic, semisyngeneic, or allogeneic epidermal
cells. We found (i) that the migration of donor Langerhans cells into
recipient epidermis was marked in Langerhans cell-depleted skin,
(ii) that only syngeneic Langerhans cells could migrate into the recipient
epidermis, though the migration of semisyngeneic or allogeneic
Langerhans cells was detected at a very low level, and (iii) that anti-
IL-6 and anti-TNF-α antibodies inhibited this migration of donor
Langerhans cells into the recipient epidermis (Saitoh et al, 1998).
Several cytokines such as GM-CSF and TNF-α have been reported
to modulate Langerhans cell migration. Intradermal injection of rGM-
CSF induced the accumulation of CD1a1, Birbeck granule-positive
Langerhans cells in the injected dermis (Kaplan et al, 1992).
Several molecules are candidates for Langerhans cell migration into
the epidermis in addition to IL-6 and TNF-α. Chemokines are
chemotactic cytokines that may play an important role for the migration
of resident cells as well as inflammatory cells. C-C chemokines
such as monocyte chemotactic protein (MCP)-1, MCP-2, MCP-3,
macrophage inflammatory protein-1 α (MIP-1 α), MIP-1 β, and
RANTES may induce migration of human DC (Xu et al, 1996). In
order to study the role of cytokines in the migration of Langerhans
cells into the skin in vivo, several transgenic (tg) mice and gene-targeted
knock-out mice were used. We previously made transgenic mice that
constitutively produced murine MCP-1 in the epidermis under the
control of human keratin 14 promoter (Nakamura et al, 1995). These
mice were entirely normal, despite the fact that MCP-1 production
by basal KC was readily demonstrable. This did not appear to be due
to desensitization and subsequent non-responsiveness of target cells to
MCP-1, because the magnitude of contact sensitivity (CS) responses
was increased in these animals. This enhancement of CS was coupled
with a redistribution of inflammatory cells from the deep dermis to
the dermal–epidermal junction. A redistribution of Langerhans cells
was also observed in MCP-1 tg mice. It was also observed that TGF-
β1 knock-out mice showed no Langerhans cells in the epidermis, and
further studies suggested that TGF-β1 produced by epidermal KC was
active as a chemoattractant to Langerhans cells (Borkowski et al,
1996, 1997).
Another molecule that may play an important role for migration of
Langerhans cells in humans is a homing molecule called cutaneous
lymphocyte-associated antigen (CLA). CLA is a special form of
P-selectin glycoprotein ligand-1 (PSGL-1), recognized by MoAb
HECA-452, and has been shown to be preferentially expressed on
human memory cutaneous T cells. These CLA positive T cells
preferentially bind to E-selectin on endothelial cells (Picker et al,
1991). Thus CLA has been regarded as a homing molecule of T cells
to the skin in various inflammatory cutaneous disorders. CLA is also
expressed on a small subpopulation of Langerhans cells in normal skin,
and the percentage of CLA expressing Langerhans cells in diseased
skin is markedly enhanced (Koszik et al, 1994). From these studies,
CLA expression on Langerhans cells is thought to be enhanced by
inflammatory cytokines. We also made a similar study of CLA expression
on Langerhans cells in normal and diseased skin (Yasaka et al, 1996).
In this study, we calculated the number of Langerhans cells in diseased
skin and observed, in addition to the findings reported by Koszik et al,
that the number of Langerhans cells was increased in most diseased
skin. Thus, we suspected that CLA on Langerhans cells might act as a
homing molecule of Langerhans cells into the skin. Further studies in
our laboratory revealed (i) that CD68 was expressed on a subpopulation
of epidermal Langerhans cells, (ii) that CLA was expressed on CD68
positive Langerhans cells, and (iii) that the percentage of CLA-
expressing cells among CD68 positive Langerhans cells was enhanced
in most diseased skin examined, e.g., in lichen planus. We also
examined MCP-1, TGF-β1, and TGF-β2 expression in epidermis of
normal and diseased skin. From these studies, it was suggested that
MCP-1 expression on human KC and CLA expression of CD681
Langerhans cells participate in the migration of Langerhans cells
into the epidermis (Nakamura et al, 1998). Recently, Strunk et al
demonstrated the existence of CLA1CD341 DC and revealed that
these DC came to show typical features of Langerhans cells such as
the expression of Birbeck granules (Strunk et al, 1997). These cells also
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expressed Langerhans cell features such as CD1a and E-cadherin. Based
on these studies, it appears that, in humans, CLA on Langerhans cells
or cells of Langerhans cell lineage may be a critical molecule for the
entry of these cells into the skin and probably into the epidermis.
Whether LCA on DC in fact regulates their migration into the skin,
and possibly into the epidermis, and what molecule is responsible for
migration of DC into other sites of the body needs to be clarified.
Thus, the mechanisms of migration of epidermal DC have been
elucidated. Our data show that selective cytokines and surface molecules
may participate in the migration of epidermal DC. Further studies,
however, are necessary to define the molecular mechanism underlying
the migration of epidermal DC. These studies will facilitate our
understanding of the biology of DC and make it possible to use them
as therapeutic tools.
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